The Comparison of Face-To-Face Unified Transdiagnostic Therapy with Internet-Based Unified Transdiagnostic Therapy in Adolescents with Depressive and Anxiety Disorders

The Comparison Of Efficacy Of Face-To-Face Unified Transdiagnostic Therapy With Internet-Based Unified Transdiagnostic Therapy In Reducing Symptoms And Improving The Function Of Adolescents With Depressive And Anxiety Disorders

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220226054129N1

Enrollment

Registered

2022-03-05

Start date

2022-04-21

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Major depressive disorder. Condition 2: Persistent mood disorders. Condition 3: Phobic anxiety disorders. Condition 4: Other anxiety disorders. Major depressive disorder, recurrent Persistent mood [affective] disorders Phobic anxiety disorders Other anxiety disorders

Interventions

Intervention 1: Intervention group: Participants in the first group will receive treatment face to face. Treatment sessions will be individual, and unified transdiagnostic treatment will be conducted

Eligibility

Sex/Gender

All

Age

12 Years to 18 Years

Inclusion criteria

Inclusion criteria: The diagnosis and the main problem of the person, based on the clinical interview by a clinical psychologist or psychiatrist, is a mood or anxiety disorder (combination of psychiatric problems including conduct disorders, attention deficit-hyperactivity disorder, eating disorders, non-interfering with treatment drug abuse, are acceptable, if the main problem is anxiety or depression). The person has not had CBT treatment for anxiety or depression in the past. Age between 12 and 18 years. If the person is taking medication, a stable dose has been reached and it is necessary that this stable dose be obtained for SSRIs three months before the start of treatment and for benzodiazepines one month before the start of treatment. Access to high speed internet at home.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The primary outcome is depression and is measured using the RCADS (Revised Child Anxiety and Depression Scale). Timepoint: The beginning of the intervention, the end of the intervention, three months after the end of the intervention. Method of measurement: RCADS (Revised Child Anxiety and Depression Scale).;The primary outcome is anxiety and is measured using the RCADS (Revised Child Anxiety and Depression Scale). Timepoint: The beginning of the intervention, the end of the intervention, three months after the end of the intervention. Method of measurement: RCADS (Revised Child Anxiety and Depression Scale).	—

Measure

Time frame

The primary outcome is depression and is measured using the RCADS (Revised Child Anxiety and Depression Scale). Timepoint: The beginning of the intervention, the end of the intervention, three months after the end of the intervention. Method of measurement: RCADS (Revised Child Anxiety and Depression Scale).;The primary outcome is anxiety and is measured using the RCADS (Revised Child Anxiety and Depression Scale). Timepoint: The beginning of the intervention, the end of the intervention, three months after the end of the intervention. Method of measurement: RCADS (Revised Child Anxiety and Depression Scale).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid Poursharifi

University of social welfare and rehabilitation sciences

poursharifih@gmail.com+98 21 2218 0045

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026